Medicamentos de actualidad = Drugs of today

• 

  Año 2021, Vol. 57, Número 2

  • MONOGRAPHS

    • An update on dapagliflozin for the treatment of heart failure.

      B. Akinci

      • Resumen

      págs. 77-88

      

    • Lasmiditan for acute treatment of migraine.

      S. Parikh

      • Resumen

      págs. 89-100

      

  • REVIEW

    • The year's new drugs & biologics 2020.

      Ann I. Graul, Lisa Ann Sorbera

      • Resumen

      págs. 101-177

      

  • NEW PRODUCT INTROS

    • New product intros [anakinra (new indication), bamlanivimab, baricitinib (new indication), BBIBP-CorV, belimumab (new indication), calcium oxybate/magnesium oxybate/potassium oxybate/sodium oxybate (new formulation), casirivimab/imdevimab, ensartinib hydrochloride, favipiravir (new indication), Gam-COVID-Vac, inactivated SARS-CoV-2 vaccine, loteprednol etabonate (new indication), lumasiran (first-in-class), mRNA-1273, rilonacept (new indication), tozinameran].

      • Resumen

      págs. 179-182